Organogenesis Holdings Inc. (FRA:2PQ)
3.920
-0.440 (-10.09%)
At close: Jan 2, 2026
Organogenesis Holdings Revenue
Organogenesis Holdings had revenue of $150.86M USD in the quarter ending September 30, 2025, with 30.98% growth. This brings the company's revenue in the last twelve months to $465.22M, up 2.24% year-over-year. In the year 2024, Organogenesis Holdings had annual revenue of $482.04M with 11.29% growth.
Revenue (ttm)
$465.22M
Revenue Growth
+2.24%
P/S Ratio
1.16
Revenue / Employee
$535.35K
Employees
869
Market Cap
459.34M EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 482.04M | 48.90M | 11.29% |
| Dec 31, 2023 | 433.14M | -17.75M | -3.94% |
| Dec 31, 2022 | 450.89M | -16.47M | -3.52% |
| Dec 31, 2021 | 467.36M | 129.06M | 38.15% |
| Dec 31, 2020 | 338.30M | 77.32M | 29.63% |
| Dec 31, 2019 | 260.98M | 67.53M | 34.91% |
| Dec 31, 2018 | 193.45M | -5.06M | -2.55% |
| Dec 31, 2017 | 198.51M | 59.78M | 43.09% |
| Dec 31, 2016 | 138.73M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Mercedes-Benz Group AG | 136.97B |
| Bayerische Motoren Werke Aktiengesellschaft | 136.42B |
| Deutsche Telekom AG | 121.02B |
| Allianz SE | 105.02B |
| Siemens Aktiengesellschaft | 78.91B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 62.10B |
| Siemens Energy AG | 39.08B |
| SAP SE | 36.49B |
Organogenesis Holdings News
- 16 days ago - Organogenesis, MiMedx among decliners as Medicare to pull skin substitute LCDs - Seeking Alpha
- 18 days ago - Organogenesis Initiates BLA Submission For ReNu In Knee Arthritis - Nasdaq
- 19 days ago - Organogenesis (ORGO) Advances ReNu BLA Submission for Knee Arthritis - GuruFocus
- 19 days ago - Organogenesis starts rolling submission for ReNu allograft for knee arthritis - Seeking Alpha
- 19 days ago - Organogenesis (ORGO) Begins Rolling Submission for FDA Approval of ReNu - GuruFocus
- 19 days ago - Organogenesis Announces Initiation of Biologics License Application for ReNu - Wallstreet:Online
- 19 days ago - Organogenesis Announces Initiation of Biologics License Application for ReNu® - GlobeNewsWire
- 26 days ago - Organogenesis To File Rolling BLA For ReNu Following FDA Meeting - Nasdaq